Skip to content

Comparing the Effects of Pathadi Taila Nasya and Xylometazoline Nasal Drops in Managing common cold

Evaluation of comparative efficacy of Pathadi Taila Navana Nasya versus 0.1 percent Xylometazoline- Hydrochloride nasal drop in the management of Peenas (Rhinitis): Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090586
Enrollment
56
Registered
2025-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

None listed

Sponsors

Dr Osama Abdul Nabi Shaikh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A patient who is willing to take part and provides signed informed consent, Patient having Peenas will be randomly selected, Selection is irrespective of gender, religion & socio economical class

Exclusion criteria

Exclusion criteria: Patients having Lower respiratory tract infections, C.S.F Rhinorrhoea and any other systemic disease, recently operated patients (Nose cases), In lactating and pregnant women

Design outcomes

Primary

MeasureTime frame
1. To assess the efficacy of Pathadi Taila Nasya on TNSS and DNE in peenas (rhinitis) 2. To assess the efficacy of 0.1 percent Xylometazoline - Hydrochloride nasal drop on TNSS and DNE in peenas (rhinitis) 3. To compare the efficacy Pathadi Taila Nasya and 0.1 percent Xylometazoline - Hydrochloride nasal drop on TNSS and DNE in peenas (rhinitis)Timepoint: 14 days

Secondary

MeasureTime frame
Relief from symptomsTimepoint: 14 days

Countries

India

Contacts

Public ContactDr Osama Abdul Nabi Shaikh

Mahatma Gandhi Ayurved College Hospital and Research Centre

drpramodborghare@hotmail.com9881225532

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026